U.S. Biomedical Leadership Threatened By NIH Licensing Guidelines

Get the Full StoryNew licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm American biotech innovation and boost China.

Share:

More in Business...

Oscar-Nominated Animated Cat Movie Flow Gets Max Streaming Date

What Is The AfD? Inside Germany's Far-Right Party

Olivia Cheng Of Dauphinette Wins Second CFDA & Genesis House AAPI Design Innovation Grant

USAID Controversy Live Updates: Judge Blocks Trump From Putting 2,200 Staff On Leave

Architect Of Influence: The PR Powerhouse Behind Artists Shaping The Future Of Music & Culture